GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » Price-to-Funds-From-Operations

BrightPath Biotherapeutics Co (TSE:4594) Price-to-Funds-From-Operations : (As of May. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


BrightPath Biotherapeutics Co (TSE:4594) Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.